Nivolumab With Chemotherapy in Refractory MDS
Clinical trial NCT03259516 · TERMINATED
Trial details
- NCT number
- NCT03259516
- Sponsor
- St. Petersburg State Pavlov Medical University
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-25
- Primary completion
- 2018-12-25
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.